project id: TCGA-SARC; case submitter id: TCGA-KD-A5QU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; age at index: 41; days to birth: -15018; days to death: 1073; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1969; age at diagnosis: 15018; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 259.0; icd 10 code: C55; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Uterus, NOS; synchronous malignancy: No; tissue or organ of origin: Uterus, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 954; initial weight: 20.0; oct embedded: false; preservation method: Unknown; sample id: 52254562-f812-4023-bb00-55e2d766eadb; sample submitter id: TCGA-KD-A5QU-01A; portion id: 87f82195-651f-49ff-b01e-58664170f675; portion submitter id: TCGA-KD-A5QU-01A-11; slide id: 46d8773f-5e6f-49b1-963d-079b74db1069; slide submitter id: TCGA-KD-A5QU-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0; section location: TOP;